Medicine

Use of vericiguat in a patient with heart failure with reduced ejection fraction and transthyretin cardiac amyloidosis: a helpful therapeutic opportunity.

Francesco Castelletti, Elena Bianco, Eleonora Nicolini, G. Bertone, C. Mongiardi, Emanuela Longo, Laura DE Ioris, Francesco Dentali, F. Tangianu, Aldo Bonaventura

2026.2.1Minerva Cardiology and Angiology

DOI: 10.23736/s2724-5683.25.07161-3

Abstract

Abstract is not available.

Citation format

CASTELLETTI, Francesco, et al. Use of vericiguat in a patient with heart failure with reduced ejection fraction and transthyretin cardiac amyloidosis: A helpful therapeutic opportunity. Minerva Cardiology and Angiology, 2026.